ClinConnect ClinConnect Logo
Search / Trial NCT02918708

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants

Launched by PUBLIC HEALTH ENGLAND · Sep 27, 2016

Trial Information

Current as of April 26, 2025

Withdrawn

Keywords

Vaccination Immunisation Pneumococcal Conjugate

ClinConnect Summary

The UK Department of Health provides a routine vaccination schedule for children in the UK which is administered by GP surgeries. The schedule is updated by the addition of antigens and amendment of products and schedules over time to improve the protection afforded to the paediatric population and the overall cost-effectiveness of the programme.

It is now well established that the effects of giving different vaccines and antigens together, as well as the order and numbers of doses given for priming and boosting, can affect the immunological responses they elicit. For example co-administra...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Infants due to receive their primary immunisations , aged up to 13 weeks on first vaccinations.
  • Written informed consent given by mother who is aged ≥\>= 16 years \[NB mother is preferable as consent also allows permission to record the date of pertussis immunisation in pregnancy, which may need to be verified in her medical record. Where mother is not available, consent may be taken from father or legal guardian and maternal pertussis status noted as not known\]
  • Exclusion Criteria:
  • Bleeding disorder
  • Fulfil any of the contraindications to vaccination as specified in The Green Book \[https://www.gov.uk/government/organisations/public-health-england/series/immunisation-against-infectious-disease-the-green-book\]

About Public Health England

Public Health England (PHE) is an executive agency of the UK Department of Health and Social Care, dedicated to protecting and improving the nation's health and well-being. As a leading sponsor of clinical trials, PHE focuses on generating robust evidence to inform public health policy and practice. The organization emphasizes the importance of research in addressing health inequalities and enhancing disease prevention strategies. Through collaboration with academic institutions, healthcare providers, and industry partners, PHE drives innovative research initiatives aimed at advancing public health outcomes across diverse populations.

Locations

London, , United Kingdom

Hertfordshire, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Elizabeth Coates, PhD

Study Chair

Public Health England

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials